MedTrace Logo

Clinical Outcomes of Patients Implanted With the RxSight Light Adjustable Lens (LAL)

NCT06488066 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2024-07-05

No results posted yet for this study

Summary

The objective of this investigator initiated study (IIT-002) is to collect data on commercial patients implanted with the RxSight Light Adjustable Lens (LAL).

Conditions

  • Cataract
  • Pseudophakia

Interventions

OTHER

Data collection

Collection of clinical data from groups of patients already implanted with the light adjustable lens (LAL) and have completed light treatments.

Sponsors & Collaborators

  • Vance Thompson Vision

    lead OTHER

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-13
Primary Completion
2022-01-01
Completion
2022-01-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06488066 on ClinicalTrials.gov